Phase II-III double-blind study of oral vinflunine plus best supportive care versus placebo plus best supportive care in patients with malignant pleural mesothelioma previously treated with systemic chemotherapy.

Trial Profile

Phase II-III double-blind study of oral vinflunine plus best supportive care versus placebo plus best supportive care in patients with malignant pleural mesothelioma previously treated with systemic chemotherapy.

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 04 Jul 2012

At a glance

  • Drugs Vinflunine (Primary)
  • Indications Mesothelioma
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jul 2012 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.
    • 04 Jul 2012 Planned end date 12 Nov 2012 added as reported by European Clinical Trials Database.
    • 04 Jul 2012 Planned number of patients changed from 309 to 396, actual initiation date (12 Nov 2008) added and additional location (France) added as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top